EODData

MEMBERSHIP REGISTER LOG IN

ASX, CUV:

10 Sep 2025
LAST:

10.89

CHANGE:
 0.09		OPEN:
11.00		HIGH:
11.28		ASK:
13.06		VOLUME:
253.7K
CHG(%):
0.83		PREV:
10.80		LOW:
10.82		BID:
12.88		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
10 Sep 2511.0011.2810.8210.89253.7K
09 Sep 2510.9311.1410.6810.80123.1K
08 Sep 2511.3111.4910.8310.94157.3K
05 Sep 2510.9911.3210.6411.28316K
04 Sep 2510.5111.5610.5010.57146.4K
03 Sep 2510.4510.5010.2710.40173.3K
02 Sep 2510.6110.8710.3210.43180.6K
01 Sep 2510.7210.9010.5010.72225.5K
29 Aug 2512.2912.2910.5010.65709.6K
28 Aug 2513.7813.9512.5312.53198.1K

COMPANY PROFILE

Name:
About:Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). The company's pipeline products include CUV9900 and Parvysmelanotide (VLRX001), both alpha-melanocyte stimulating hormone analogue; and PRÉNUMBRA, a liquid injectable formulation of afamelanotide. It is also developing NEURACTHEL (ACTH), an adrenocorticotropic hormone to produce cortisol and enables the combat of stress and regulation of immune responses, maintenance of blood pressure, moderation of blood sugar, and regulation of metabolism. The company was incorporated in 1999 and is headquartered in Melbourne, Australia.
Sector:Healthcare
Industry:Biotechnology
Address:535 Bourke Street, Melbourne, VIC, Australia, 3000
Website:https://www.clinuvel.com
ISIN:AU000000CUV3
FIGI:BBG000C41K83

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

P/E Ratio:17.19
DivYield:0.00
Div/Share:0.05
Price to Book:3.05
Price to Sales:7.29
EBITDA:51.73M
Shares:50.12M
Market Cap:545.85M

TECHNICAL INDICATORS

MA5:10.90
MA10:10.92
MA20:11.77
MA50:11.66
MA100:11.11
MA200:11.43
STO9:25.93
STO14:13.61
RSI14:41.67
WPR14:-85.15
MTM14:-2.04
ROC14:-0.16
ATR:0.80
Week High:11.56
Week Low:10.27
Month High:14.00
Month Low:10.27
Year High:15.99
Year Low:9.41

RECENT SPLITS

Date Ratio
11 Nov 20101-10
05 Oct 20061-1

RECENT DIVIDENDS

Date Amount
05 Sep 2024$0.05
05 Sep 2023$0.05
06 Sep 2022$0.04
02 Sep 2021$0.03
03 Sep 2020$0.03
04 Sep 2019$0.03
21 Sep 2018$0.02